2018
DOI: 10.1016/j.sapharm.2017.11.011
|View full text |Cite
|
Sign up to set email alerts
|

A content review of online naloxone Continuing Education courses for pharmacists in states with standing orders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
33
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 16 publications
(34 citation statements)
references
References 15 publications
1
33
0
Order By: Relevance
“…42 Pharmacist willingness to dispense naloxone is affected also by confidence of pharmacists in addition to time constraints, lack of support from management or prescribers, and perceived lack of patient understanding. 38,39,45 Naloxone training and education programs…”
Section: Science and Practicementioning
confidence: 99%
See 3 more Smart Citations
“…42 Pharmacist willingness to dispense naloxone is affected also by confidence of pharmacists in addition to time constraints, lack of support from management or prescribers, and perceived lack of patient understanding. 38,39,45 Naloxone training and education programs…”
Section: Science and Practicementioning
confidence: 99%
“…Five studies examined training and education programs for practicing pharmacists. 45,[47][48][49][50] State-mandated training requirements were reviewed for pharmacists dispensing naloxone in states where the legislatures permitted enhanced access to naloxone through pharmacies. 47 To date, all states except Nebraska have enhanced pharmacy naloxone access laws, including 43 states with standing orders and 14 state with protocol orders.…”
Section: Programs For Practicing Pharmacistsmentioning
confidence: 99%
See 2 more Smart Citations
“…Under each of these circumstances, the clinical decision to engage in enhanced naloxone dispensing activities requires pharmacists to understand how to appropriately screen prospective naloxone recipients, counsel patients and third-party caregivers on recognizing and treating opioid overdose with specific naloxone delivery devices, and both immediate and long-term patient care management after naloxone administration. 8 Additional education may also be required to inform pharmacists about their liability protections when engaging in enhanced naloxone dispensing activities and address misconceptions about naloxone, such as the belief that its use encourages highrisk opioid use behaviors. 9 The purpose of this paper is to review each state's current legislatively-mandated training requirements that pharmacists must complete prior to engaging in enhanced naloxone dispensing activities.…”
Section: Introductionmentioning
confidence: 99%